Mobocertinib is a special type of EGFR inhibitor. It’s made just for NSCLC patients with a specific kind of EGFR mutation. It stops tumor growth by going after the EGFR.
That’s a fancy way of saying it targets a part of the cancer cells. You take it as pills, and they’re 40 mg each. It’s just a number, but in this case, that’s the strength you need.
You should take it once a day for 160 mg. You don’t have to worry about food – it works either way. Each bottle has 90 capsules.
